Valuation Caplin Point Laboratories Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. Other stock markets 04:35:07 12/06/2026 pm IST			5-day change	1st Jan Change
2,407.80 ^INR	+3.29%		+18.43%	+30.99%

15/05	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
15/05	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	1,00,038	1,52,221	1,83,287	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	20.41%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	1,00,038	1,52,221	1,83,287	1,83,287	1,83,287
Change	-	68.55%	-12.11%	120.88%	52.16%	20.41%	0%	0%
P/E Ratio	12.7x	17.3x	12.1x	22x	28.5x	17.9x	25.7x	22.5x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.16x	3.78x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.6x	1.6x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	7.37x	6.53x
EV / Revenue	0x	0x	0x	0x	0x	8.61x	7.37x	6.53x
EV / EBITDA	0x	0x	0x	0x	0x	24.7x	21.3x	18.7x
EV / EBIT	0x	0x	0x	-	0x	23.6x	19.7x	17x
EV / FCF	0x	0x	0x	0x	0x	48.2x	33.3x	33.9x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	3%	2.95%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.17%	0.17%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	93.8	107
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.26%	3.74%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	24,880	28,053
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,604	9,810
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,128	8,124
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,411.30	2,411.30	2,411.30
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	06/05/21	12/05/22	27/05/23	16/05/24	15/05/25	14/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	37.29x	7.06x	24.07x	0.83%	4.56TCr
OTSUKA HOLDINGS CO., LTD.	17.01x	1.89x	8.98x	1.43%	3.35TCr
CIPLA LIMITED	26.82x	3.3x	16.88x	0.9%	1.18TCr
ZYDUS LIFESCIENCES LIMITED	24.23x	4.23x	15.75x	0.73%	1.17TCr
KRKA, D. D.	19.49x	3.37x	12.21x	3.5%	912.1Cr
GEDEON RICHTER	8.33x	1.96x	5.12x	5.2%	716.41Cr
ONO PHARMACEUTICAL CO., LTD.	14.59x	1.91x	7.25x	3.68%	649.02Cr
GLENMARK PHARMACEUTICALS LIMITED	33x	3.75x	15.96x	0.24%	645.39Cr
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	41.73x	-	-	-	515.65Cr
Average	24.72x	3.43x	13.28x	2.06%	1.52TCr
Weighted average by Cap.	26.50x	4.21x	15.78x	1.51%